The EORTC 10041/BIG 03–04 MINDACT (Microarray in Node Negative and 1 to 3 Positive Lymph Node Disease May Avoid ChemoTherapy) Trial: Patients' Baseline Characteristics and Logistics Aspects After a Successful Accrual

Autor:	J-Y Pierga, Kristel Engelen, Jan Bogaerts, L van 't Veer, G. Viale, S. Delaloge, Ulrike Nitz, G. Werutsky, E.J.T. Rutgers, Isabel T. Rubio, Fatima Cardoso, M.J. Piccart, A. Thompson, Rodolfo Passalacqua, Camilo Moulin, Peter Vuylsteke
Rok vydání:	2011
Předmět:	Oncology Cancer Research medicine.medical_specialty Chemotherapy Microarray Accrual business.industry medicine.medical_treatment Disease Node negative Surgery Internal medicine Baseline characteristics medicine Positive lymph node business
Zdroj:	European Journal of Cancer. 47:7
ISSN:	0959-8049
DOI:	10.1016/s0959-8049(11)70109-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::87e97efbd1534f8bb2820e14ed8d2aed https://doi.org/10.1016/s0959-8049(11)70109-5 Zobrazit plný text záznamu Full Text from ScienceDirect